uk 68798 has been researched along with Arrhythmia in 91 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 10 (10.99) | 18.2507 |
2000's | 40 (43.96) | 29.6817 |
2010's | 30 (32.97) | 24.3611 |
2020's | 11 (12.09) | 2.80 |
Authors | Studies |
---|---|
Baizman, ER; Becker, C; Bell, RH; Birsner, NC; Bohnet, EA; Busacca, CA; Carabateas, PM; Chadwick, CC; Gruett, MD; Johnson, RE | 1 |
Jia, L; Sun, H | 1 |
Jacob, S; Nichols, J; Prousi, G; Smith, S; Tanner, H | 1 |
Beekman, HDM; Bossu, A; Bourgonje, V; Dunnink, A; Meine, M; Oros, A; Salden, OA; Stams, T; Ter Horst, I; van Weperen, VYH; Vos, MA | 1 |
Dobrev, D; Grundland, A; Heijman, J; Meier, S; Volders, PGA | 1 |
Baroudi, S; Basset, M; Benito, S; Dayan, F; Koloskoff, K; Llopis-Lorente, J; Mora, MT; Romero, L; Saiz, J; Trenor, B | 1 |
Shen, C; Stabenau, HF; Tereshchenko, LG; Waks, JW | 1 |
Brelidze, TI; Rybka, V; Shults, NV; Suzuki, YJ | 1 |
Burattini, L; Laratta, R; Marcantoni, I; Mascia, G; Morettini, M; Nasim, A; Ricciardi, L; Sbrollini, A | 1 |
Aghasafari, P; Bekker, S; Clancy, CE; Dawson, JRD; DeMarco, KR; Jeng, MT; Noskov, SY; Vorobyov, I; Yang, PC; Yarov-Yarovoy, V | 1 |
Becker, N; Brinkwirth, N; Doi, M; Fertig, N; Friis, S; Furukawa, H; Hasegawa, Y; Obergrussberger, A; Ohtsuki, A; Oka, T; Stoelzle-Feix, S; Takasuna, K | 1 |
Bai, S; Cao, H; Chen, K; Dong, H; Ma, Y; Pei, J; Tian, L; Zhao, Y | 1 |
Clausen, C; Cohen, IS; Cui, J; Gao, J; Grinter, SZ; Hou, P; Kang, PW; Liang, H; Lin, Y; Liu, Y; Lu, Z; Ma, Z; Shi, J; Wang, HZ; White, KM; Xu, X; Zhang, G; Zhao, L; Zhao, W; Zou, X | 1 |
Clancy, CE; DeMarco, KR; Harvey, RD; Jeng, MT; Kurokawa, J; López-Redondo, F; Noskov, SY; Perissinotti, LL; Vorobyov, I; Wang, Y; Yang, PC | 1 |
Hamlin, RL; Kijtawornrat, A; Limprasutr, V; Meedech, P; Saengklub, N | 1 |
Bhargava, M; Cho, JH; Chung, MK; Kyriakakis, R; Lindsay, BD; Militello, M; Moore, JC; Niebauer, MJ; Poe, SM; Saliba, WI; Tchou, PJ; Varma, N; Vekstein, C; Wazni, OM; Wilkoff, BL; Wolski, K; Youn, SJ | 1 |
Briceño, DF; Supple, GE | 1 |
Osadchii, OE | 3 |
Beekman, HDM; Belardinelli, L; Bossu, A; de Bakker, JMT; Dunnink, A; Houtman, MJC; Meijborg, VMF; Mollova, N; Rajamani, S; van der Heyden, MAG; Varkevisser, R; Vos, MA | 1 |
Arbel, G; Chorna, SV; Gepstein, A; Gepstein, L; Goldfracht, I; Gruber, A; Huber, I; Setter, N; Shaheen, N; Shinnawi, R; Shiti, A | 1 |
Benson, C; Brown, R; Couderc, JP; Darpo, B; Dota, C; Ferber, G; Ferry, J; Jarugula, V; Keirns, J; Ortemann-Renon, C; Pham, T; Riley, S; Sarapa, N; Ticktin, M; Zareba, W | 1 |
Ababneh, DH; Oakes, DJ; Power, CA; Ritchie, HE; Webster, WS | 1 |
Beekman, HD; de Git, KC; Houtman, MJ; Ijzerman, AP; Linder, T; Stary-Weinzinger, A; Tidwell, RR; van der Heyden, MA; Varkevisser, R; Vos, MA | 1 |
Beekman, HD; Bourgonje, VJ; Oosterhoff, P; Schoenmakers, M; Stams, TR; van der Nagel, R; van Opstal, JM; Vos, MA | 1 |
Csík, N; Farkas, A; Farkas, AS; Farkas, S; Forster, T; Orosz, S; Papp, JG; Sarusi, A; Varró, A | 1 |
Champeroux, P; Fowler, JS; Judé, S; Laigot-Barbé, C; Le Guennec, JY; Maurin, A; Richard, S; Sola, ML; Thireau, J | 1 |
Bányász, T; Hegyi, B; Horváth, B; Kistamás, K; Magyar, J; Nánási, PP; Szentandrássy, N; Váczi, K | 1 |
Fukushima, T; Hata, Y; Hisajima, N; Kano, M; Kinoshita, K; Nishida, N; Tabata, T | 1 |
Cools, F; Danhof, M; Gallacher, DJ; Gotta, V; Morissette, P; Sannajust, F; van Ammel, K; van der Graaf, PH; Visser, SA | 1 |
't Hart, IM; Heitman, LH; IJzerman, AP; Kopf, AH; van Veldhoven, JP; Yu, Z | 1 |
Albert, D; Albert, M; Chohan, J; Garabelli, P; Koomson, E; Parwani, P; Po, S; Reynolds, D; Smith, L; Stavrakis, S; Xie, Q; Xie, R | 1 |
Beekman, JD; Dunnink, A; Heijdel, A; Oosterhoff, P; Stams, TR; van der Heyden, MA; van der Nagel, R; van Rijen, HV; Vos, MA | 1 |
Shenasa, F; Shenasa, M | 1 |
Gold, MR; Leman, RB; Simon, RD; Sturdivant, JL; Wharton, JM | 1 |
Andersson, B; Carlsson, L; Linhardt, G; Löfberg, L | 1 |
Abi-Gerges, N; Crijns, HJ; Heijman, J; Johnson, DM; Pollard, CE; Valentin, JP; Volders, PG | 1 |
Beekman, J; Dunnink, A; Montagne, D; Oosterhoff, P; Sharif, S; van der Heyden, MA; van der Nagel, R; Vos, MA; Winckels, S | 1 |
Csanády, M; Csík, N; Farkas, A; Farkas, AS; Forster, T; Leprán, I; Makra, P; Papp, JG; Rudas, L; Varró, A | 1 |
Ducroq, J; Legrand, JC; Puddu, PE; Rouet, R; Sallé, L | 1 |
Hamlin, RL; Kijtawornrat, A; Sawangkoon, S | 1 |
Antoons, G; Beekman, JD; Bourgonje, VJ; de Windt, LJ; Houtman, MJ; Miedema, LF; Schoenmakers, M; Sipido, K; van der Nagel, R; van Veen, TA; Vos, MA | 1 |
Benites, P; Bozek, J; Kagan, M; Lamoy, M; Onthank, D; Robinson, SP; Yu, M | 1 |
Afshartous, D; Balser, JR; Baudenbacher, FJ; Campbell, CM; Chaigne, S; Days, E; Engers, DW; George, AL; Hopkins, CR; Kupershmidt, S; Lewis, LM; Li, M; Lindsley, CW; Lorinc, AN; Potet, F; Sidorov, VY; Stepanovic, SZ; Venkataraman, R; Weaver, CD; Zou, B | 1 |
Crijns, HJ; Vos, MA | 1 |
Burchardt, H; Hintze, U; Møller, M; Vach, W; Videbaek, J | 1 |
DeBisschop, M; Lower, DL; Martin, LG; Yamreudeewong, W | 1 |
Brendorp, B; Elming, H; Køber, L; Pedersen, OD; Torp-Petersen, C | 1 |
Anyukhovsky, EP; Danilo, P; Gainullin, RZ; Obreztchikova, MN; Plotnikov, A; Robinson, RB; Rosen, MR; Sosunov, EA; Yeom, ZH | 1 |
Pratt, CM | 1 |
Beekman, JD; Bischoff, U; Frederiksen, K; Kall, MA; Matz, J; Spätjens, RL; Stengl, M; Thomsen, MB; Volders, PG; Vos, MA | 1 |
Allen LaPointe, NM; Califf, RM; Chen, A; DeLong, E; Hammill, B; Kramer, JM | 1 |
Chazov, EI; Glushkov, RG; Golitsyn, SP; Iuzhakov, SD; L'vov, AI; Rozenshtraukh, LV; Ruda, MIa | 1 |
Li, WZ | 1 |
Blessing, WW; De Pasquale, CG; Nalivaiko, E | 1 |
Gerlach, U; Nakashima, H; Nattel, S; Schmidt, D | 1 |
Dong, DL; Du, ZM; Li, Z; Song, WH; Wang, HZ; Yang, BF | 1 |
Brendorp, B; Elming, H; Køber, L; Pedersen, OD; Pehrson, S; Torp-Petersen, C | 1 |
Ducouret, P; Ducroq, J; Gérard, JL; Puddu, PE; Rouet, R; Sallé, L; Tabourel, C | 1 |
Bradley, JA; Cass, JD; Chen, X; Dahm, CM; Engwall, MJ; Kadyszewski, E; Sun, Z; Zhou, J | 1 |
Ducouret, P; Ducroq, J; Gérard, JL; Ghadanfar, M; Puddu, PE; Repessé, Y; Rouet, R; Sallé, L | 1 |
Coleman, CI; Guertin, D; Henyan, NN; Kluger, J; McBride, BF; Min, B; Silver, BB; White, CM | 1 |
Attevelt, NJ; Beekman, JD; Chiba, K; Sugiyama, A; Takahara, A; Thomsen, MB; Vos, MA | 1 |
Roukoz, H; Saliba, W | 1 |
Beekman, JD; Maas, JN; Oros, A; Schoenmakers, M; Thomsen, MB; van Opstal, JM; Vos, MA | 1 |
Guo, D; Kowey, PR; Liu, T; Wu, Y; Yan, GX; Zhao, X | 1 |
Grant, AO; Tranquillo, J | 1 |
Brendel, J; Gögelein, H; Linz, DK; Rütten, H; Steinmeyer, K; Wirth, KJ | 1 |
Chen, J; Eto, K; Hashimoto, K; Ni, C; Xue, Y | 1 |
Møller, M | 1 |
Bharucha, D; Kowey, PR; Marinchak, RA; Rials, SJ | 1 |
Brown, AM; Dennis, A; Rampe, D; Roy, ML | 1 |
Sager, PT | 2 |
Al-Khalidi, H; Brooks, RR; Drexler, AP; Kostreva, DR; Maynard, AE | 1 |
Kalus, JS; Mauro, VF | 1 |
Kondo, M; Mashima, S; Tsutsumi, T | 1 |
Hilleman, DE; Lenz, TL | 1 |
Doshi, SK; Singh, BN | 1 |
Brendorp, B; Elming, H; Jensen, GB; Jun, L; Køber, L; Malik, M; Torp-Pedersen, C | 1 |
Al-Dashti , R; Sami , M | 1 |
Camm, AJ | 1 |
Anderson, ME; Bonney, S; Mazur, A; Roden, DM | 1 |
De Clerck, F; Lu, HR; Remeysen, P; Saels, A; Somers, K | 1 |
Pham, TV; Rosen, MR | 1 |
Reiffel, JA | 1 |
Khan, IA | 1 |
Allen, MJ; Blackburn, KJ; Butrous, GS; Dalrymple, HW; Rasmussen, HS | 1 |
Honerjäger, P; Schmidt, G | 1 |
21 review(s) available for uk 68798 and Arrhythmia
Article | Year |
---|---|
Combining pharmacokinetic and electrophysiological models for early prediction of drug-induced arrhythmogenicity.
Topics: Arrhythmias, Cardiac; DNA-Binding Proteins; Female; Humans; Male; Potassium; Sulfonamides; Torsades de Pointes | 2023 |
Inter-study variability of preclinical in vivo safety studies and translational exposure-QTc relationships--a PKPD meta-analysis.
Topics: Animals; Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Dogs; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Fluoroquinolones; Heart Conduction System; Heart Rate; Humans; Long QT Syndrome; Male; Moxifloxacin; Phenethylamines; Potassium Channel Blockers; Reproducibility of Results; Sotalol; Sulfonamides; Telemetry; Translational Research, Biomedical | 2015 |
Dofetilide: Electrophysiologic Effect, Efficacy, and Safety in Patients with Cardiac Arrhythmias.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Phenethylamines; Sulfonamides | 2016 |
Myocardial repolarization and drugs. Impossibility to predict the dominance of anti-arrhythmic over pro-arrhythmic effects of drugs due to differential and ventricular electrical remodeling.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Disease Models, Animal; Humans; Phenethylamines; Sulfonamides; Tachycardia, Ventricular; Torsades de Pointes | 2001 |
Potentially significant drug interactions of class III antiarrhythmic drugs.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Compounds; Drug Interactions; Humans; Phenethylamines; Sotalol; Sulfonamides | 2003 |
Dofetilide: a new drug to control cardiac arrhythmia.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Clinical Trials as Topic; Humans; Phenethylamines; Practice Guidelines as Topic; Product Surveillance, Postmarketing; Sulfonamides; Tachycardia, Supraventricular | 2003 |
Pure class III agents for prevention of sudden cardiac death.
Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Comorbidity; Death, Sudden, Cardiac; Europe; Humans; Hydantoins; Imidazoles; Imidazolidines; Middle Aged; Myocardial Infarction; Phenethylamines; Piperazines; Randomized Controlled Trials as Topic; Sotalol; Sulfonamides; Survival Analysis; Treatment Outcome | 2003 |
A benefit-risk assessment of class III antiarrhythmic agents.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Combined Modality Therapy; Defibrillators, Implantable; Dronedarone; Heart Conduction System; Humans; Hydantoins; Imidazolidines; Ion Transport; Life Tables; Membrane Potentials; Meta-Analysis as Topic; Phenethylamines; Piperazines; Risk Assessment; Sotalol; Sulfonamides; Survival Analysis; Torsades de Pointes; Treatment Outcome | 2004 |
Dofetilide: a new class III antiarrhythmic agent.
Topics: Action Potentials; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Dose-Response Relationship, Drug; Drug Interactions; Electrophysiologic Techniques, Cardiac; Heart Failure; Humans; Phenethylamines; Randomized Controlled Trials as Topic; Sulfonamides; Tachycardia, Supraventricular; Torsades de Pointes; Ventricular Function, Left | 2007 |
Pharmacologic and pharmacokinetic profile of class III antiarrhythmic drugs.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Compounds; Humans; Phenethylamines; Sotalol; Sulfonamides | 1997 |
New advances in class III antiarrhythmic drug therapy.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Denmark; Humans; Hydantoins; Imidazoles; Imidazolidines; Phenethylamines; Piperazines; Postoperative Complications; Potassium Channel Blockers; Randomized Controlled Trials as Topic; Sulfonamides | 1999 |
New advances in class III antiarrhythmic drug therapy.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrophysiology; Humans; Hydantoins; Imidazoles; Imidazolidines; Phenethylamines; Piperazines; Sotalol; Sulfonamides | 2000 |
Dofetilide: a class III-specific antiarrhythmic agent.
Topics: Adult; Aged; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Phenethylamines; Sulfonamides | 2000 |
Dofetilide, a new class III antiarrhythmic agent.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Phenethylamines; Sulfonamides | 2000 |
Pure class III antiarrhythmic drugs: focus on dofetilide.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disease Models, Animal; Dogs; Electrophysiology; Heart Failure; Humans; Phenethylamines; Sulfonamides | 2000 |
Dofetilide: a new class III antiarrhythmic agent.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Phenethylamines; Potassium Channel Blockers; Sulfonamides | 2001 |
Clinical differences between the newer antiarrhythmic agents.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bridged Bicyclo Compounds, Heterocyclic; Cyclopropanes; Dronedarone; Heart Conduction System; Humans; Hydantoins; Imidazoles; Imidazolidines; Phenethylamines; Piperazines; Sulfonamides | 2000 |
Sex, hormones, and repolarization.
Topics: Aging; Animals; Arrhythmias, Cardiac; Electrocardiography; Electrophysiology; Female; Gonadal Steroid Hormones; Humans; Ion Channels; Long QT Syndrome; Male; Myocardium; Phenethylamines; Potassium Channel Blockers; Rabbits; Receptors, Androgen; Receptors, Estrogen; Sex; Sulfonamides | 2002 |
Transient atrial mechanical dysfunction (stunning) after cardioversion of atrial fibrillation and flutter.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Appendage; Atrial Fibrillation; Atrial Flutter; Catheter Ablation; Dogs; Electric Countershock; Heart Atria; Humans; Myocardial Contraction; Myocardial Stunning; Phenethylamines; Regional Blood Flow; Sotalol; Sulfonamides; Ultrasonography; Verapamil | 2002 |
Dofetilide, a novel class III antiarrhythmic agent.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiography; Electrophysiology; Heart; Humans; Phenethylamines; Sulfonamides | 1992 |
[New anti-arrhythmia agents].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiography; Humans; Phenethylamines; Procainamide; Propanolamines; Sotalol; Sulfonamides; Survival Rate; Tachycardia | 1992 |
5 trial(s) available for uk 68798 and Arrhythmia
Article | Year |
---|---|
Evaluation of the Effect of 5 QT-Positive Drugs on the JTpeak Interval - An Analysis of ECGs From the IQ-CSRC Study.
Topics: Arrhythmias, Cardiac; Biomarkers; Cetirizine; Drug-Related Side Effects and Adverse Reactions; Electrocardiography; Female; Fluoroquinolones; Healthy Volunteers; Heart Conduction System; Heart Rate; Humans; Indoles; Ion Channels; Long QT Syndrome; Male; Moxifloxacin; Ondansetron; Phenethylamines; Quinine; Quinolizines; Risk Assessment; Sulfonamides | 2020 |
The effect of dofetilide on ventricular defibrillation thresholds.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Combined Modality Therapy; Electric Countershock; Female; Humans; Male; Middle Aged; Phenethylamines; Sulfonamides; Treatment Outcome; Ventricular Dysfunction | 2009 |
An evaluation of the impact of oral magnesium lactate on the corrected QT interval of patients receiving sotalol or dofetilide to prevent atrial or ventricular tachyarrhythmia recurrence.
Topics: Administration, Oral; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chi-Square Distribution; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Female; Humans; Lactic Acid; Magnesium Compounds; Male; Phenethylamines; Recurrence; Sotalol; Statistics, Nonparametric; Sulfonamides; Treatment Outcome | 2006 |
DIAMOND antiarrhythmic trials. Danish Investigations of Arrhythmia and Mortality on Dofetilide.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Denmark; Heart Failure; Humans; Myocardial Infarction; Patient Selection; Phenethylamines; Risk; Sulfonamides | 1996 |
Pause-dependent polymorphic ventricular tachycardia during long-term treatment with dofetilide: a placebo-controlled, implantable cardioverter-defibrillator-based evaluation.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Defibrillators, Implantable; Double-Blind Method; Electrocardiography; Female; Humans; Male; Middle Aged; Phenethylamines; Sulfonamides; Tachycardia, Ventricular; Torsades de Pointes | 2001 |
65 other study(ies) available for uk 68798 and Arrhythmia
Article | Year |
---|---|
4,5-Dihydro-1-phenyl-1H-2,4-benzodiazepines: novel antiarrhythmic agents.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzodiazepines; Cats; Disease Models, Animal; Dogs; Guinea Pigs; Heart Ventricles; Male; Myocardial Contraction; Myocardial Infarction; Potassium Channels; Rats; Rats, Sprague-Dawley; Refractory Period, Electrophysiological; Sodium Channels; Structure-Activity Relationship | 1993 |
Support vector machines classification of hERG liabilities based on atom types.
Topics: Animals; Arrhythmias, Cardiac; CHO Cells; Computer Simulation; Cricetinae; Cricetulus; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Chemical; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Predictive Value of Tests; ROC Curve | 2008 |
"Third Time's a Charm": Three Times Per Day Dosing of Dofetilide May Be Beneficial in Refractory Atrial Arrhythmias.
Topics: Arrhythmias, Cardiac; Humans; Phenethylamines; Sulfonamides | 2022 |
Chronically altered ventricular activation causes pro-arrhythmic cardiac electrical remodelling in the chronic AV block dog model.
Topics: Animals; Arrhythmias, Cardiac; Atrial Remodeling; Atrioventricular Block; Cardiac Resynchronization Therapy; DNA-Binding Proteins; Dogs; Heart | 2023 |
In silico analysis of the dynamic regulation of cardiac electrophysiology by K
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrophysiologic Techniques, Cardiac; Ether-A-Go-Go Potassium Channels; Humans; Hypokalemia; Ion Channels; Myocytes, Cardiac | 2023 |
Changes in global electrical heterogeneity associated with dofetilide, quinidine, ranolazine, and verapamil.
Topics: Adult; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Female; Heart Ventricles; Humans; Male; Phenethylamines; Potassium Channel Blockers; Quinidine; Ranolazine; Risk Assessment; Sodium Channel Blockers; Sulfonamides; Treatment Outcome | 2020 |
Increased Smooth Muscle Kv11.1 Channel Expression in Pulmonary Hypertension and Protective Role of Kv11.1 Channel Blocker Dofetilide.
Topics: Adult; Aged; Aged, 80 and over; Animals; Arrhythmias, Cardiac; Case-Control Studies; ERG1 Potassium Channel; Female; Follow-Up Studies; Humans; Male; Muscle, Smooth, Vascular; Phenethylamines; Potassium Channel Blockers; Prognosis; Pulmonary Arterial Hypertension; Rats, Sprague-Dawley; Sulfonamides; Vascular Remodeling | 2020 |
Dofetilide-Induced Microvolt T-Wave Alternans.
Topics: Arrhythmias, Cardiac; Electrocardiography; Humans; Phenethylamines; Sulfonamides | 2019 |
A Computational Pipeline to Predict Cardiotoxicity: From the Atom to the Rhythm.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiotoxicity; Cardiotoxins; Computer Simulation; Drug Discovery; ERG1 Potassium Channel; Female; Humans; Long QT Syndrome; Machine Learning; Male; Moxifloxacin; Myocytes, Cardiac; Phenethylamines; Protein Structure, Secondary; Sulfonamides; Topoisomerase II Inhibitors | 2020 |
Reliable identification of cardiac liability in drug discovery using automated patch clamp: Benchmarking best practices and calibration standards for improved proarrhythmic assessment.
Topics: Animals; Arrhythmias, Cardiac; Astemizole; Benchmarking; Calibration; Cardiovascular Agents; Cell Line; CHO Cells; Cricetulus; Drug Discovery; Drug Evaluation, Preclinical; ERG1 Potassium Channel; Heart; HEK293 Cells; Humans; Patch-Clamp Techniques; Phenethylamines; Polypropylenes; Polytetrafluoroethylene; Reference Standards; Reproducibility of Results; Sulfonamides; Terfenadine | 2020 |
Assessment of Drug Proarrhythmic Potential in Electrically Paced Human Induced Pluripotent Stem Cell-Derived Ventricular Cardiomyocytes Using Multielectrode Array.
Topics: Action Potentials; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium; Cations, Divalent; Cell Differentiation; Humans; Induced Pluripotent Stem Cells; Ion Transport; Microelectrodes; Models, Biological; Myocardial Contraction; Myocytes, Cardiac; Nifedipine; Patch-Clamp Techniques; Phenethylamines; Primary Cell Culture; Quinidine; Sotalol; Sulfonamides; Tetrodotoxin; Verapamil | 2021 |
Modulating the voltage sensor of a cardiac potassium channel shows antiarrhythmic effects.
Topics: Action Potentials; Amino Acid Substitution; Animals; Arrhythmias, Cardiac; Calcium; Dogs; Furans; Gene Expression; Guinea Pigs; Heart Atria; Heart Ventricles; Humans; KCNQ1 Potassium Channel; Moxifloxacin; Myocytes, Cardiac; Oocytes; Patch-Clamp Techniques; Phenethylamines; Potassium; Primary Cell Culture; Pyridines; Pyrimidines; Small Molecule Libraries; Sodium; Sulfonamides; Transgenes; Xenopus laevis | 2021 |
A multiscale computational modelling approach predicts mechanisms of female sex risk in the setting of arousal-induced arrhythmias.
Topics: Adrenergic beta-Agonists; Animals; Anti-Arrhythmia Agents; Arousal; Arrhythmias, Cardiac; Estradiol; Ether-A-Go-Go Potassium Channels; Female; Guinea Pigs; Isoproterenol; Male; Models, Biological; Molecular Docking Simulation; Myocytes, Cardiac; Phenethylamines; Sex Characteristics; Sulfonamides | 2017 |
Characteristics of electromechanical window in anesthetized rabbit models of short QT and long QT syndromes.
Topics: Anesthesia; Animals; Arrhythmias, Cardiac; Benzopyrans; Biomarkers; Biomarkers, Pharmacological; Cromakalim; Disease Models, Animal; Electrocardiography; Isoflurane; Long QT Syndrome; Phenethylamines; Pinacidil; Quinidine; Rabbits; Risk; Sulfonamides; Systole; Torsades de Pointes; Ventricular Pressure | 2017 |
Safety of Oral Dofetilide Reloading for Treatment of Atrial Arrhythmias.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Administration Schedule; Drug Dosage Calculations; Electrocardiography, Ambulatory; Female; Heart Atria; Heart Rate; Humans; Male; Medical Records; Middle Aged; Patient Admission; Phenethylamines; Predictive Value of Tests; Retrospective Studies; Risk Factors; Sulfonamides; Time Factors; Torsades de Pointes; Treatment Outcome | 2017 |
Dofetilide Reloaded: To Admit or Not to Admit, That is the Question.
Topics: Arrhythmias, Cardiac; Humans; Phenethylamines; Sulfonamides | 2017 |
Arrhythmogenic drugs can amplify spatial heterogeneities in the electrical restitution in perfused guinea-pig heart: An evidence from assessments of monophasic action potential durations and JT intervals.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrophysiological Phenomena; Female; Flecainide; Guinea Pigs; In Vitro Techniques; Perfusion; Phenethylamines; Procainamide; Quinidine; Sulfonamides | 2018 |
Selective late sodium current inhibitor GS-458967 suppresses Torsades de Pointes by mostly affecting perpetuation but not initiation of the arrhythmia.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dogs; Dose-Response Relationship, Drug; Myocytes, Cardiac; Phenethylamines; Pyridines; Sulfonamides; Torsades de Pointes; Triazoles | 2018 |
Human Induced Pluripotent Stem Cell-Derived Cardiac Cell Sheets Expressing Genetically Encoded Voltage Indicator for Pharmacological and Arrhythmia Studies.
Topics: Action Potentials; Arrhythmias, Cardiac; Biomarkers; Gene Expression; Humans; Induced Pluripotent Stem Cells; Models, Biological; Molecular Imaging; Myocytes, Cardiac; Phenethylamines; Sulfonamides | 2018 |
Effects of antiarrhythmics on the electrical restitution in perfused guinea-pig heart are critically determined by the applied cardiac pacing protocol.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Electrocardiography; Female; Guinea Pigs; Heart; Heart Conduction System; Heart Ventricles; Phenethylamines; Quinidine; Refractory Period, Electrophysiological; Sulfonamides; Ventricular Fibrillation | 2019 |
The teratogenic effect of dofetilide during rat limb development and association with drug-induced bradycardia and hypoxia in the embryo.
Topics: Abnormalities, Drug-Induced; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bradycardia; Heart; Hypoxia; Limb Deformities, Congenital; Nitroimidazoles; Phenethylamines; Rats; Rats, Sprague-Dawley; Sulfonamides; Teratogens | 2013 |
Structure-activity relationships of pentamidine-affected ion channel trafficking and dofetilide mediated rescue.
Topics: Animals; Anti-Arrhythmia Agents; Antiprotozoal Agents; Arrhythmias, Cardiac; Cell Membrane; Dogs; Endocytosis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; HEK293 Cells; Humans; Kinetics; Membrane Transport Modulators; Mice; Molecular Dynamics Simulation; Pentamidine; Phenethylamines; Potassium Channel Blockers; Recombinant Proteins; Shab Potassium Channels; Structure-Activity Relationship; Sulfonamides | 2013 |
The electromechanical window is no better than QT prolongation to assess risk of Torsade de Pointes in the complete atrioventricular block model in dogs.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Remodeling; Atrioventricular Block; Databases, Factual; Delayed Rectifier Potassium Channels; Disease Models, Animal; Disease Susceptibility; Dogs; Early Diagnosis; Electrocardiography; Female; Heart; Heart Rate; Male; Phenethylamines; Potassium Channel Blockers; Reproducibility of Results; Sulfonamides; Torsades de Pointes | 2014 |
Impaired epicardial activation-repolarization coupling contributes to the proarrhythmic effects of hypokalaemia and dofetilide in guinea pig ventricles.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Electrocardiography; Female; Guinea Pigs; Heart Conduction System; Heart Ventricles; Hypokalemia; Myocardial Contraction; Phenethylamines; Potassium Channel Blockers; Refractory Period, Electrophysiological; Sulfonamides | 2014 |
Assessment of efficacy of proarrhythmia biomarkers in isolated rabbit hearts with attenuated repolarization reserve.
Topics: Animals; Arrhythmias, Cardiac; Biomarkers; Chromans; Dose-Response Relationship, Drug; Electrocardiography; Female; Phenethylamines; Rabbits; Sulfonamides; Torsades de Pointes | 2014 |
Short-term variability in QT interval and ventricular arrhythmias induced by dofetilide are dependent on high-frequency autonomic oscillations.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Autonomic Nervous System; Dogs; Electrophysiological Phenomena; Ganglionic Blockers; Heart Ventricles; Hexamethonium; Macaca fascicularis; Myocytes, Cardiac; Phenethylamines; Sulfonamides; Torsades de Pointes | 2015 |
Cytosolic calcium changes affect the incidence of early afterdepolarizations in canine ventricular myocytes.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Action Potentials; Animals; Arrhythmias, Cardiac; Calcium; Calcium Channel Agonists; Calcium Chelating Agents; Cells, Cultured; Cytosol; Dogs; Egtazic Acid; Female; Heart Ventricles; Male; Myocytes, Cardiac; Phenethylamines; Sulfonamides; Time Factors; Veratridine | 2015 |
The Susceptibilities of Human Ether-à-Go-Go-Related Gene Channel with the G487R Mutation to Arrhythmogenic Factors.
Topics: Action Potentials; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Ether-A-Go-Go Potassium Channels; Genotype; Heart; Heart Conduction System; HEK293 Cells; Humans; Hypokalemia; Ion Channel Gating; Kinetics; Long QT Syndrome; Mutation; Patch-Clamp Techniques; Phenethylamines; Phenotype; Potassium; Potassium Channel Blockers; Sulfonamides | 2015 |
Synthesis and biological evaluation of negative allosteric modulators of the Kv11.1(hERG) channel.
Topics: Acetamides; Allosteric Regulation; Arrhythmias, Cardiac; Cells, Cultured; Dose-Response Relationship, Drug; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; HEK293 Cells; Humans; Kinetics; Molecular Structure; Naphthyridines; Phenethylamines; Potassium Channel Blockers; Pyridines; Structure-Activity Relationship; Sulfonamides | 2015 |
Comparison of QT Interval Readings in Normal Sinus Rhythm Between a Smartphone Heart Monitor and a 12-Lead ECG for Healthy Volunteers and Inpatients Receiving Sotalol or Dofetilide.
Topics: Action Potentials; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Case-Control Studies; Electrocardiography; Female; Healthy Volunteers; Heart Rate; Humans; Inpatients; Male; Middle Aged; Mobile Applications; Phenethylamines; Predictive Value of Tests; Reproducibility of Results; Smartphone; Sotalol; Sulfonamides | 2016 |
Beat-to-Beat Variability in Preload Unmasks Latent Risk of Torsade de Pointes in Anesthetized Chronic Atrioventricular Block Dogs.
Topics: Action Potentials; Anesthesia; Animals; Arrhythmias, Cardiac; Atrioventricular Block; Dogs; Phenethylamines; Risk; Streptomycin; Sulfonamides; Torsades de Pointes | 2016 |
Assessment of the ion channel-blocking profile of the novel combined ion channel blocker AZD1305 and its proarrhythmic potential versus dofetilide in the methoxamine-sensitized rabbit in vivo.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium Channel Blockers; Calcium Channels, L-Type; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Inhibitory Concentration 50; Long QT Syndrome; Male; Methoxamine; Phenethylamines; Potassium Channel Blockers; Rabbits; Sulfonamides; Time Factors | 2009 |
I(Ks) restricts excessive beat-to-beat variability of repolarization during beta-adrenergic receptor stimulation.
Topics: Action Potentials; Aniline Compounds; Animals; Arrhythmias, Cardiac; Calcium; Cells, Cultured; Dogs; Egtazic Acid; Female; Heart Ventricles; Ion Channels; Isoproterenol; Myocytes, Cardiac; Phenethylamines; Phenyl Ethers; Potassium; Potassium Channel Blockers; Potassium Channels; Receptors, Adrenergic, beta; Sodium; Sodium-Calcium Exchanger; Sulfonamides | 2010 |
Anesthesia and arrhythmogenesis in the chronic atrioventricular block dog model.
Topics: Anesthesia; Animals; Arrhythmias, Cardiac; Atrioventricular Block; Dogs; Female; Halothane; Heart Block; Isoflurane; Male; Phenethylamines; Sulfonamides; Thiopental; Torsades de Pointes | 2010 |
Biomarkers and endogenous determinants of dofetilide-induced torsades de pointes in α(1) -adrenoceptor-stimulated, anaesthetized rabbits.
Topics: Adrenergic alpha-1 Receptor Agonists; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Baroreflex; Biomarkers; Electrocardiography; Female; Heart; Phenethylamines; Phenylephrine; Rabbits; Receptors, Adrenergic, alpha-1; Sulfonamides; Torsades de Pointes | 2010 |
I(Kr) vs. I(Ks) blockade and arrhythmogenicity in normoxic rabbit Purkinje fibers: does it really make a difference?
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chromans; Delayed Rectifier Potassium Channels; Epinephrine; Hydantoins; Imidazolidines; In Vitro Techniques; Male; Phenethylamines; Piperazines; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Purkinje Fibers; Rabbits; Sotalol; Sulfonamides | 2011 |
Assessment of QT-prolonging drugs in the isolated normal and failing rabbit hearts.
Topics: Animals; Arrhythmias, Cardiac; Cisapride; Electrocardiography; Feasibility Studies; Glucose; Heart; Heart Failure; In Vitro Techniques; Male; Models, Animal; Phenethylamines; Quinidine; Rabbits; Sulfonamides; Torsades de Pointes; Tromethamine | 2012 |
Relevance of calmodulin/CaMKII activation for arrhythmogenesis in the AV block dog.
Topics: Animals; Arrhythmias, Cardiac; Atrioventricular Block; Benzylamines; Calcineurin; Calcium-Binding Proteins; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cardiomyopathy, Hypertrophic; Cyclosporine; Disease Models, Animal; Dogs; Isoproterenol; Long QT Syndrome; Myocytes, Cardiac; Patch-Clamp Techniques; Phenethylamines; Phenotype; Phosphorylation; Random Allocation; Sulfonamides; Ventricular Remodeling | 2012 |
LMI1195 PET imaging in evaluation of regional cardiac sympathetic denervation and its potential role in antiarrhythmic drug treatment.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Autonomic Nerve Block; Cell Line, Tumor; Fluorobenzenes; Guanidines; Heart; Heart Rate; Heart Ventricles; Humans; Phenethylamines; Phenol; Positron-Emission Tomography; Rabbits; Radiopharmaceuticals; Sulfonamides | 2012 |
Identification and characterization of a compound that protects cardiac tissue from human Ether-à-go-go-related gene (hERG)-related drug-induced arrhythmias.
Topics: Animals; Arrhythmias, Cardiac; Dose-Response Relationship, Drug; Drug Discovery; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; HEK293 Cells; Humans; Muscle Proteins; Myocardium; Naphthyridines; Phenethylamines; Potassium Channel Blockers; Pyridines; Rabbits; Structure-Activity Relationship; Sulfonamides | 2012 |
QT interval dynamics predict mortality in high-risk patients after myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiography, Ambulatory; Female; Follow-Up Studies; Heart Rate; Humans; Male; Multivariate Analysis; Myocardial Infarction; Observer Variation; Phenethylamines; Predictive Value of Tests; Prospective Studies; Risk Factors; Sulfonamides; Survival Analysis; Treatment Outcome; Ventricular Dysfunction, Left | 2002 |
Developmental changes in IKr and IKs contribute to age-related expression of dofetilide effects on repolarization and proarrhythmia.
Topics: Action Potentials; Aging; Animals; Animals, Newborn; Arrhythmias, Cardiac; Dogs; Female; Male; Membrane Potentials; Myocardium; Patch-Clamp Techniques; Phenethylamines; Potassium Channel Blockers; Potassium Channels; Sulfonamides | 2003 |
Electrophysiological safety of sertindole in dogs with normal and remodeled hearts.
Topics: Action Potentials; Animals; Antipsychotic Agents; Arrhythmias, Cardiac; Dogs; Electrophysiology; Heart; Imidazoles; Indoles; Myocytes, Cardiac; Phenethylamines; Sulfonamides | 2003 |
Evaluation of the dofetilide risk-management program.
Topics: Arrhythmias, Cardiac; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Electrocardiography; Female; Guideline Adherence; Humans; Incidence; Male; Middle Aged; North Carolina; Phenethylamines; Practice Guidelines as Topic; Product Labeling; Program Evaluation; Risk Management; Sotalol; Sulfonamides; Torsades de Pointes | 2003 |
[Development of original Russian antiarrhythmic drugs of the 3rd class].
Topics: Adolescent; Adult; Aged; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzamides; Clinical Trials as Topic; Dogs; Electrocardiography; Female; Humans; Male; Middle Aged; Phenethylamines; Potassium Channel Blockers; Purkinje Fibers; Rabbits; Russia; Sulfonamides; Time Factors | 2003 |
[Progress in the clinical use of anti-arrhythmic drugs (I)].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Child; Clinical Trials as Topic; Humans; Hydantoins; Imidazoles; Imidazolidines; Phenethylamines; Piperazines; Sulfonamides | 2003 |
Ventricular arrhythmias triggered by alerting stimuli in conscious rabbits pre-treated with dofetilide.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Arousal; Arrhythmias, Cardiac; Electrocardiography; Formaldehyde; Heart; Heart Ventricles; Isoproterenol; Motion; Pain; Phenethylamines; Physical Stimulation; Premedication; Propranolol; Rabbits; Stimulation, Chemical; Sulfonamides | 2004 |
In vivo electrophysiological effects of a selective slow delayed-rectifier potassium channel blocker in anesthetized dogs: potential insights into class III actions.
Topics: Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Chromans; Dogs; Electrocardiography; Electrophysiology; Female; Male; Myocardium; Nadolol; Phenethylamines; Potassium Channel Blockers; Potassium Channels, Inwardly Rectifying; Sulfonamides | 2004 |
Acidification alters antiarrhythmic drug blockade of the ether-a-go-go-related Gene (HERG) Channels.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Delayed Rectifier Potassium Channels; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Hydantoins; Hydrogen-Ion Concentration; Imidazoles; Imidazolidines; Myocardial Ischemia; Oocytes; Patch-Clamp Techniques; Phenethylamines; Piperazines; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Quinidine; Sulfonamides; Transfection; Xenopus | 2004 |
Electrophysiological effects of azimilide in an in vitro model of simulated-ischemia and reperfusion in guinea-pig ventricular myocardium.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chromans; Dose-Response Relationship, Drug; Female; Guinea Pigs; Heart Ventricles; Hydantoins; Imidazolidines; In Vitro Techniques; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Phenethylamines; Piperazines; Potassium Channel Blockers; Sulfonamides; Time Factors | 2005 |
QT prolongation and proarrhythmia by moxifloxacin: concordance of preclinical models in relation to clinical outcome.
Topics: Action Potentials; Animals; Anti-Infective Agents; Area Under Curve; Arrhythmias, Cardiac; Aza Compounds; Cell Line; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Electrocardiography; Ether-A-Go-Go Potassium Channels; Female; Fluoroquinolones; Humans; Long QT Syndrome; Male; Moxifloxacin; Phenethylamines; Potassium Channels, Inwardly Rectifying; Quinolines; Rabbits; Sulfonamides; Telemetry; Treatment Outcome | 2005 |
Class III effects of dofetilide and arrhythmias are modulated by [K+]o in an in vitro model of simulated-ischemia and reperfusion in guinea-pig ventricular myocardium.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dose-Response Relationship, Drug; Guinea Pigs; Heart; Heart Ventricles; Hyperkalemia; In Vitro Techniques; Kinetics; Models, Animal; Myocardial Reperfusion Injury; Myocardium; Phenethylamines; Potassium; Potassium Channel Blockers; Sulfonamides | 2006 |
No proarrhythmic properties of the antibiotics Moxifloxacin or Azithromycin in anaesthetized dogs with chronic-AV block.
Topics: Anesthesia; Animals; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Arrhythmias, Cardiac; Aza Compounds; Azithromycin; Dogs; Dose-Response Relationship, Drug; Electric Stimulation; Electroencephalography; Electrophysiology; Fluoroquinolones; Heart Block; Heart Rate; Long QT Syndrome; Moxifloxacin; Phenethylamines; Quinolines; Sulfonamides; Torsades de Pointes | 2006 |
Proarrhythmic electrical remodelling is associated with increased beat-to-beat variability of repolarisation.
Topics: Action Potentials; Acute Disease; Animals; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Dogs; Electrocardiography; Female; Heart Block; Heart Conduction System; Heart Rate; Male; Phenethylamines; Potassium Channel Blockers; Sulfonamides; Torsades de Pointes; Ventricular Remodeling | 2007 |
L-type calcium current reactivation contributes to arrhythmogenesis associated with action potential triangulation.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium Channel Blockers; Calcium Channels, L-Type; Guinea Pigs; Hydantoins; Imidazolidines; In Vitro Techniques; Myocytes, Cardiac; Nicardipine; Patch-Clamp Techniques; Phenethylamines; Piperazines; Rabbits; Sulfonamides | 2007 |
Action potential and QT prolongation not sufficient to cause Torsade de Pointes: role of action potential triangulation.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium Channel Blockers; Calcium Channels, L-Type; Guinea Pigs; Hydantoins; Imidazolidines; Myocytes, Cardiac; Nicardipine; Patch-Clamp Techniques; Phenethylamines; Piperazines; Rabbits; Sulfonamides; Torsades de Pointes | 2007 |
In vitro and in vivo effects of the atrial selective antiarrhythmic compound AVE1231.
Topics: Action Potentials; Analysis of Variance; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Function; Blood Flow Velocity; Carbachol; Cardiotonic Agents; CHO Cells; Cricetinae; Cricetulus; Disease Models, Animal; Dose-Response Relationship, Drug; Electrophysiologic Techniques, Cardiac; Female; Goats; Guinea Pigs; Heart Atria; Heart Ventricles; Humans; Inhibitory Concentration 50; Ion Channels; Male; Myocytes, Cardiac; Papillary Muscles; Patch-Clamp Techniques; Phenethylamines; Potassium Channel Blockers; Refractory Period, Electrophysiological; Sulfonamides; Swine; Time Factors | 2007 |
Effects of dofetilide, a class III antiarrhythmic drug, on various ventricular arrhythmias in dogs.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Vessels; Digitalis; Disease Models, Animal; Dogs; Electric Stimulation; Electrocardiography; Epinephrine; Female; Male; Myocardial Infarction; Myocardial Reperfusion; Phenethylamines; Plants, Medicinal; Plants, Toxic; Sulfonamides; Tachycardia, Ventricular; Ventricular Fibrillation | 1996 |
A mechanism for the proarrhythmic effects of cisapride (Propulsid): high affinity blockade of the human cardiac potassium channel HERG.
Topics: Arrhythmias, Cardiac; Cation Transport Proteins; Cell Line; Cisapride; DNA-Binding Proteins; Electrophysiology; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Heart; Humans; Kv1.5 Potassium Channel; Myocardium; Patch-Clamp Techniques; Phenethylamines; Piperidines; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Sulfonamides; Terfenadine; Trans-Activators; Transcriptional Regulator ERG; Transfection; Tumor Cells, Cultured | 1997 |
Dofetilide. UK 68, UK 68798, Tikosyn, Xelide.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dogs; Drug Interactions; Drugs, Investigational; Guinea Pigs; Humans; In Vitro Techniques; Phenethylamines; Potassium Channel Blockers; Sulfonamides | 1999 |
Proarrhythmia of azimilide and other class III antiarrhythmic agents in the adrenergically stimulated rabbit.
Topics: Adrenergic alpha-Agonists; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disease Models, Animal; Female; Hemodynamics; Hydantoins; Imidazoles; Imidazolidines; Male; Methoxamine; Phenethylamines; Piperazines; Procainamide; Quaternary Ammonium Compounds; Rabbits; Sotalol; Sulfonamides | 2000 |
Potassium channel openers antagonize the effects of class III antiarrhythmic agents in canine Purkinje fiber action potentials. Implications for prevention of proarrhythmia induced by class III agents.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dogs; Phenethylamines; Piperidines; Potassium Channel Blockers; Potassium Channels; Purkinje Fibers; Pyridines; Sulfonamides | 1999 |
Qt dispersion has no prognostic information for patients with advanced congestive heart failure and reduced left ventricular systolic function.
Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Denmark; Double-Blind Method; Electrocardiography; Follow-Up Studies; Heart Failure; Humans; Middle Aged; Observer Variation; Phenethylamines; Prognosis; Sulfonamides; Survival Analysis; Ventricular Dysfunction, Left | 2001 |
Female gender is a risk factor for drug-induced long QT and cardiac arrhythmias in an in vivo rabbit model.
Topics: Adrenergic alpha-1 Receptor Agonists; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Disease Models, Animal; Electrocardiography; Female; Heart Rate; Incidence; Long QT Syndrome; Male; Methoxamine; Models, Cardiovascular; Phenethylamines; Rabbits; Receptors, Adrenergic, alpha-1; Risk Factors; Sex Factors; Sulfonamides; Treatment Outcome; Women's Health | 2001 |
Is it rational, reasonable or excessive, and consistently applied? One view of the increasing FDA emphasis on safety first for the release and use of antiarrhythmic drugs for supraventricular arrhythmias.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Approval; Drugs, Generic; Heart Ventricles; Humans; Hydantoins; Imidazoles; Imidazolidines; Phenethylamines; Piperazines; Sotalol; Sulfonamides; United States; United States Food and Drug Administration | 2001 |